Assignee
KARUNA THERAPEUTICS INC
US·8 granted patents·7 pending applications·15 citations·filing 2019–2025
Top patents by PatentIndex Score
15 records- 0194US10925832B2Compositions and methods for treatment of disorders ameliorated by muscarinic receptor activationKARUNA THERAPEUTICS INC·Filed 2020·Granted Feb 23, 2021·5 cites·18 claims
- 0293US11452692B2Compositions and methods for treating disorders ameliorated by muscarinic receptor activationKARUNA THERAPEUTICS INC·Filed 2022·Granted Sep 27, 2022·2 cites·18 claims
- 0392US11890378B2Compositions and methods for treating disorders ameliorated by muscarinic receptor activationKARUNA THERAPEUTICS INC·Filed 2022·Granted Feb 6, 2024·1 cites·14 claims
- 0491US11471413B2Compositions and methods for treating disorders ameliorated by muscarinic receptor activationKARUNA THERAPEUTICS INC·Filed 2021·Granted Oct 18, 2022·2 cites·21 claims
- 0589US10933020B2Compositions and methods for treating disorders ameliorated by muscarinic receptor activationKARUNA THERAPEUTICS INC·Filed 2019·Granted Mar 2, 2021·5 cites·46 claims
- 0687US12558317B2Compositions and methods for treating disorders ameliorated by muscarinic receptor activationKARUNA THERAPEUTICS INC·Filed 2023·Granted Feb 24, 2026·0 cites·76 claims
- 0773US12421242B2Substituted tetrahydropyrrolo-pyridinone compounds and their use in treating medical conditionsKARUNA THERAPEUTICS INC·Filed 2024·Granted Sep 23, 2025·0 cites·50 claims
- 0873US2021154146A1Compositions and methods for treating disorders ameliorated by muscarinic receptor activationKARUNA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0968US2026055116A1Substituted tetrahydropyrrolo-pyridinone compounds and their use in treating medical conditionsKARUNA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1063US2025228832A1Methods for treating disorders ameliorated by muscarinic receptor activationKARUNA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1159US2024156802A1Methods for treating disorders ameliorated by muscarinic receptor activationKARUNA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1259US2022370454A1Methods for treating central nervous system disorders with muscarinic receptor activation and antipsychoticsKARUNA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1351US2021145804A1Compositions and methods for treating disorders ameliorated by muscarinic receptor activationKARUNA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1446US11534434B2Xanomeline derivatives and methods for treating neurological disordersKARUNA THERAPEUTICS INC·Filed 2020·Granted Dec 27, 2022·0 cites·15 claims
- 1543US2022144817A1Compounds and methods of deuterated xanomeline for treating neurological disordersKARUNA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when KARUNA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →